Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound bismuth potassium citrate plus omeprazole for Helicobacter pylori eradication in active duodenal ulcer
ChiCTR-TRC-13003143Phase 2Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of compound bismuth potassium citrate and omeprazole in Helicobacter pylori infection and duodenal ulcer (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2013; status: completed.
02
Drugs
compound bismuth potassium citrateomeprazole
03
Conditions
Helicobacter pylori infectionduodenal ulcer
Beyond the preview
Go deeper on ChiCTR-TRC-13003143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003143.